Guo H C, Michel J B, Blouquit Y, Chapman M J
INSERM Unité 321, Hôpital de la Pitié, Paris, France.
Arterioscler Thromb. 1991 Jul-Aug;11(4):1030-41. doi: 10.1161/01.atv.11.4.1030.
In an earlier report (Chapman et al, Biochemistry 1979;18:5096-5108), we suggested that the common marmoset may represent an important model for the study of human plasma lipoprotein metabolism. We now extend the interest of this monkey model to the study of lipoprotein(a) (Lp[a]) and apolipoprotein(a) (apo[a]). Density gradient ultracentrifugal fractionation of marmoset plasma revealed a bimodal distribution of Lp(a), with one peak of concentration occurring in association with very low density lipoproteins (VLDLs) and a second in the density range 1.040-1.080 g/ml. The dense Lp(a) subspecies displayed physicochemical properties (chemical composition, particle size, and electrophoretic mobility) that closely resembled those of its counterpart in humans and baboons but that were distinct from those of low density lipoprotein (LDL). Furthermore, the particle size of marmoset Lp(a) was invariant (31 nm) over the density interval 1.040-1.080 g/ml, whereas that of LDL decreased progressively with an increase in density (approximately 26-25.2 nm). Use of polyclonal and monoclonal antibodies to human apo(a) and of a polyclonal antibody to marmoset Lp(a) allowed immunologic identification of a single apo(a) isoform in the marmoset whose size was similar to that of apo B-100; apo(a) and apo B-100 were associated in Lp(a) particles by a disulfide linkage. The total protein mass of apo-Lp(a) was estimated to be 800,000 or more by electrophoresis in sodium dodecyl sulfate-polyacrylamide-agarose gels. The amino acid compositions of marmoset and human apo(a) resembled each other but were distinct from those of the corresponding forms of apo B-100. Immunologic evidence is provided for a high degree of cross reactivity between apo(a) in marmosets, baboons, and humans, supporting the idea of the existence of a marked degree of structural homology between these proteins. In addition, electroimmunoblotting of marmoset apo(a) and marmoset plasminogen showed that these proteins shared certain epitopes in common, suggesting that marmoset apo(a) may possess kringle-like structural features. Finally, despite possession of a single apo(a) isoform, marmoset Lp(a) levels varied over a 100-fold range (0.5-49 mg/dl plasma). Considered together, our present findings suggest that the common marmoset monkey constitutes a unique model in which to study the regulation of apo(a) gene expression and the posttranslational processing of apo(a), as well as factors that modulate the synthesis, intravascular metabolism, and cellular catabolism of Lp(a).
在较早的一份报告中(查普曼等人,《生物化学》,1979年;18:5096 - 5108),我们提出普通狨猴可能是研究人类血浆脂蛋白代谢的重要模型。我们现在将这种猴模型的研究兴趣扩展到脂蛋白(a) [Lp(a)] 和载脂蛋白(a) [apo(a)] 的研究。对狨猴血浆进行密度梯度超速离心分级分离显示,Lp(a) 呈双峰分布,一个浓度峰值与极低密度脂蛋白(VLDL)相关,另一个在密度范围1.040 - 1.080 g/ml。致密的Lp(a) 亚类表现出的物理化学性质(化学组成、颗粒大小和电泳迁移率)与人类和狒狒中的对应物非常相似,但与低密度脂蛋白(LDL)不同。此外,狨猴Lp(a) 在密度区间1.040 - 1.080 g/ml 内颗粒大小不变(31 nm),而LDL 的颗粒大小随着密度增加而逐渐减小(约26 - 25.2 nm)。使用针对人apo(a) 的多克隆和单克隆抗体以及针对狨猴Lp(a) 的多克隆抗体,通过免疫鉴定发现狨猴中有一种单一的apo(a) 同工型,其大小与apo B - 100 相似;apo(a) 和apo B - 100 通过二硫键在Lp(a) 颗粒中结合。通过在十二烷基硫酸钠 - 聚丙烯酰胺 - 琼脂糖凝胶中电泳,估计apo - Lp(a) 的总蛋白质量为800,000 或更高。狨猴和人apo(a) 的氨基酸组成彼此相似,但与相应形式的apo B - 100 不同。提供了免疫证据表明狨猴、狒狒和人apo(a) 之间存在高度交叉反应性,支持了这些蛋白质之间存在显著结构同源性的观点。此外,对狨猴apo(a) 和狨猴纤溶酶原的电免疫印迹显示这些蛋白质有某些共同的表位,表明狨猴apo(a) 可能具有类似kringle 的结构特征。最后,尽管狨猴只有一种apo(a) 同工型,但狨猴Lp(a) 水平在100 倍范围内变化(血浆中0.5 - 49 mg/dl)。综合考虑,我们目前的研究结果表明普通狨猴构成了一个独特的模型,可用于研究apo(a) 基因表达的调控、apo(a) 的翻译后加工以及调节Lp(a) 的合成、血管内代谢和细胞分解代谢的因素。